The team


Dr Anna Schuh, MD, PhD, MRCP, FRCPath

Dr Anna Schuh is a consultant haematologist at Oxford University Hospitals. Her main research interests are with chronic lymphocytic leukaemia (CLL) and molecular diagnostics. She is a principle/chief investigator on a number of early and late Phase clinical trials in CLL. As the Head of the MDC, she leads on a translational research programme for the development, validation, standardisation and evaluation of clinical utility of NGS technologies. Her particular focus is with improving response prediction in CLL and other malignancies using whole genome sequencing. She receives grants from NIHR, Wellcome Trust and the Technology Strategy Board. She is an active member of the NCRN CLL subgroup and the NCRN biomarker and imaging group.

Dr Chris Hatton, FRCP, FRCPath

Dr Chris Hatton is a Consultant Haematologist at the Oxford Radcliffe Hospitals NHS Trust where he is the lead clinician for lymphoma and is chair of the regional Thames Valley Cancer Network (TVCN) for clinical haematology.

Dr Chris Hatton has a strong interest in the diagnosis of lymphoproliferative disease by flowcytometry and leads the immunophenotyping service of the laboratory. His research interests include the immune response to lymphoma and MicroRNA expression in lymphoid malignancies. He is member of the NRCI Low Grade Lymphoma group and is a trustee for the National Lymphoma Association.

© 2017 Oxford Molecular Diagnostic Centre. All rights reserved.

Last updated 23 Feb 2017.